Literature DB >> 34797725

Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.

Marc A Pfeffer1, Brian Claggett1, Eldrin F Lewis2, Christopher B Granger3, Lars Køber4, Aldo P Maggioni5, Douglas L Mann6, John J V McMurray7, Jean-Lucien Rouleau8, Scott D Solomon1, Philippe Gabriel Steg9, Otavio Berwanger10, Maja Cikes11, Carmine G De Pasquale12, Alberto Fernandez13, Gerasimos Filippatos14, Karola Jering1, Ulf Landmesser15, Venugopal Menon16, Béla Merkely17, Mark C Petrie1, Ivo Petrov18, Morten Schou19, Michele Senni20, David Sim21, Peter van der Meer22, Martin Lefkowitz23, Yinong Zhou23, Yi Wang23, Eugene Braunwald24.   

Abstract

Entities:  

Keywords:  heart failure; myocardial infarction; ramipril; sacubitril/valsartan

Mesh：

Substances：

Year:  2021        PMID： 34797725      PMCID： PMC8716414          DOI： 10.1161/CIRCULATIONAHA.121.057429

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  The Primary Outcome Fails - What Next?

Authors:  Stuart J Pocock; Gregg W Stone
Journal:  N Engl J Med       Date:  2016-09-01       Impact factor: 91.245

2.  Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.

Authors:  Eric J Velazquez; David A Morrow; Adam D DeVore; Carol I Duffy; Andrew P Ambrosy; Kevin McCague; Ricardo Rocha; Eugene Braunwald
Journal:  N Engl J Med       Date:  2018-11-11       Impact factor: 91.245

3.  Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.

Authors:  Marc A Pfeffer; Brian Claggett; Eldrin F Lewis; Christopher B Granger; Lars Køber; Aldo P Maggioni; Douglas L Mann; John J V McMurray; Jean-Lucien Rouleau; Scott D Solomon; Philippe G Steg; Otavio Berwanger; Maja Cikes; Carmine G De Pasquale; Cara East; Alberto Fernandez; Karola Jering; Ulf Landmesser; Roxana Mehran; Béla Merkely; Freny Vaghaiwalla Mody; Mark C Petrie; Ivo Petrov; Morten Schou; Michele Senni; David Sim; Peter van der Meer; Martin Lefkowitz; Yinong Zhou; Jianjian Gong; Eugene Braunwald
Journal:  N Engl J Med       Date:  2021-11-11       Impact factor: 91.245

4.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

5.  Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics.

Authors:  Karola S Jering; Brian Claggett; Marc A Pfeffer; Christopher Granger; Lars Køber; Eldrin F Lewis; Aldo P Maggioni; Douglas Mann; John J V McMurray; Jean-Lucien Rouleau; Scott D Solomon; Philippe G Steg; Peter van der Meer; Margaret Wernsing; Katherine Carter; Weinong Guo; Yinong Zhou; Martin Lefkowitz; Jianjian Gong; Yi Wang; Bela Merkely; Stella M Macin; Urmil Shah; Jose C Nicolau; Eugene Braunwald
Journal:  Eur J Heart Fail       Date:  2021-04-22       Impact factor: 17.349
  5 in total
  5 in total

1.  Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.

Authors:  Amil M Shah; Brian Claggett; Narayana Prasad; Guichu Li; Mayra Volquez; Karola Jering; Maja Cikes; Attila Kovacs; Wilfried Mullens; Jose C Nicolau; Lars Køber; Peter van der Meer; Pardeep S Jhund; Ghionul Ibram; Martin Lefkowitz; Yinong Zhou; Scott D Solomon; Marc A Pfeffer
Journal:  Circulation       Date:  2022-09-09       Impact factor: 39.918

Review 2.  Insights into foundational therapies for heart failure with reduced ejection fraction.

Authors:  John J V McMurray; Kieran F Docherty
Journal:  Clin Cardiol       Date:  2022-06       Impact factor: 3.287

3.  Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial.

Authors:  Niklas Dyrby Johansen; Daniel Modin; Joshua Nealon; Sandrine Samson; Camille Salamand; Carsten Schade Larsen; Brian L Claggett; Scott D Solomon; Martin J Landray; Gunnar H Gislason; Lars Køber; Jens Ulrik Stæhr Jensen; Pradeesh Sivapalan; Lasse Skafte Vestergaard; Palle Valentiner-Branth; Tyra Grove Krause; Tor Biering-Sørensen
Journal:  Pilot Feasibility Stud       Date:  2022-04-21

Review 4.  Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases.

Authors:  Hitoshi Nakagawa; Yoshihiko Saito
Journal:  Biology (Basel)       Date:  2022-07-06

Review 5.  Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.

Authors:  Stefan Frantz; Moritz Jens Hundertmark; Jeanette Schulz-Menger; Frank Michael Bengel; Johann Bauersachs
Journal:  Eur Heart J       Date:  2022-07-14       Impact factor: 35.855
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.